Pipeline

ALT-803

IL-15 Superagonist Technology

NMI Bladder Cancer

  • Pre-IND
  • Phase 1
  • Phase 2

NCT02138734 – View Trial Details

Heme Malignancy post-ASCT

  • Pre-IND
  • Phase 1
  • Phase 2

NCT01885897 – View Trial Details

Multiple Myeloma

  • Pre-IND
  • Phase 1
  • Phase 2

NCT02099539 – View Trial Details

Pancreatic Cancer

  • Pre-IND
  • Phase 1
  • Phase 2

NCT02559674 – View Trial Details

Solid Tumors

  • Pre-IND
  • Phase 1
  • Phase 2

NCT01946789 – View Trial Details

Indolent Non-Hodgkin Lymphoma

  • Pre-IND
  • Phase 1
  • Phase 2

NCT02384954 – View Trial Details

Non-small Cell Lung Cancer

  • Pre-IND
  • Phase 1
  • Phase 2

NCT02523469 – View Trial Details

HIV

  • Pre-IND
  • Phase 1
  • Phase 2

NCT02191098 – View Trial Details

ALT-801

STAR™ Technology

Advanced Bladder Cancer

  • Pre-IND
  • Phase 1
  • Phase 2

NCT01326871 – View Trial Details

Metastatic Melanoma

  • Pre-IND
  • Phase 1
  • Phase 2

NCT01029873 – View Trial Details

NMI Bladder Cancer

  • Pre-IND
  • Phase 1
  • Phase 2

NCT01625260 – View Trial Details